30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Ted Love

Track

Insider profile

Currently holds positions in Santarus Inc, Amicus Therapeutics Inc, Portola Pharmaceuticals Inc and Global Blood Therapeutics Inc

Positions

Position Company Period
Independent Director Santarus Inc March 18, 2005 -
Independent Director Amicus Therapeutics Inc June 13, 2012 -
Independent Director Portola Pharmaceuticals Inc Sept. 19, 2019 -
President, Chief Executive Officer, Director Global Blood Therapeutics Inc June 1, 2014 -
Independent Director Cascadian Therapeutics Inc Sept. 5, 2013 - March 9, 2018
Lead Independent Director Humanigen Inc May 28, 2015 - Nov. 19, 2015
Independent Chairman of the Board Humanigen Inc May 1, 2014 - May 28, 2015
Independent Director Humanigen Inc March 1, 2009 - May 1, 2014
Independent Director Savara Inc Sept. 5, 2012 - Aug. 7, 2013
Independent Director Bio Rad Laboratories Inc March 24, 2010 - April 23, 2013
Executive Vice President, Head - Research and Development and Technical Operations Onyx Pharmaceuticals Inc Jan. 1, 2011 - Aug. 1, 2012
Ted Love's trades of Global Blood Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-04-29 2020-04-28
PlS Planned sale
97,593 +23.4%
82.48
US$3,784,735 		97,593 +23.4% 82.48 US$3,784,735
2020-04-29 2020-04-27
PlS Planned sale
4,391 -12.7%
252.27
US$3,037,678 		4,391 -12.7% 252.27 US$3,037,678
2020-04-29 2020-04-27
PlS Planned sale
18,504 -32.9%
231.00
US$3,137,730 		18,504 -32.9% 231.00 US$3,137,730
2020-02-20 2020-02-18
PlS Planned sale
1,818 -0.2%
70.92
US$128,940 		1,818 -0.2% 70.92 US$128,940
2020-02-20 2020-02-18
PlS Planned sale
2,189 -0.2%
70.22
US$153,721 		2,189 -0.2% 70.22 US$153,721
2020-01-23 2020-01-22
PlS Planned sale
1,031 -0.1%
82.45
US$85,011 		1,031 -0.1% 82.45 US$85,011
2020-01-23 2020-01-22
PlS Planned sale
32,150 -2.9%
81.85
US$2,631,600 		32,150 -2.9% 81.85 US$2,631,600
2020-01-23 2020-01-22
PlS Planned sale
6,819 -0.6%
81.01
US$552,436 		6,819 -0.6% 81.01 US$552,436
2020-01-23 2020-01-21
PlS Planned sale
523 -0.0%
83.56
US$43,703 		523 -0.0% 83.56 US$43,703
2020-01-23 2020-01-21
PlS Planned sale
10,166 -0.9%
82.78
US$841,562 		10,166 -0.9% 82.78 US$841,562
2020-01-23 2020-01-21
PlS Planned sale
29,311 -2.6%
81.98
US$2,402,837 		29,311 -2.6% 81.98 US$2,402,837